Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of DEZLORA 5 mg vs AERIUS 5 mg in healthy Thai volunteers under fasting conditions
TCTR20250929003Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of desloratadine in allergic rhinitis (AR) and urticaria (2 arms), sponsored by International Bio Service. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
desloratadine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on TCTR20250929003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250929003.